For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Thinking of trying ivermectin for COVID? Here’s what can happen with this controversial drug
+News
Thinking of trying ivermectin for COVID? Here’s what can happen with this controversial drug
Friday 3 September 2021, 03:57 PM

Health authorities are concerned at the number of people taking ivermectin, and warn against it for anyone else who may have COVID symptoms or has been diagnosed with the virus. Image: TajPharmaImages / WikiCommons CC-BY SA 4.0
by Nial Wheate, University of Sydney; Andrew McLachlan, University of Sydney, and Slade Matthews, University of Sydney
Westmead Hospital in Sydney’s west says it has treated a patient who overdosed after taking the drug ivermectin, an unproven and potentially dangerous
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.